New class drug significantly reduces spine fracture risk in postmenopausal women with osteoporosis – EurekAlert (press release)

New class drug significantly reduces spine fracture risk in postmenopausal women with osteoporosisEurekAlert (press release)Madrid, Spain, 14 June 2017: The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference showed that, in postmenopausal women with osteoporosis, 12 months treatment with romosozumab …and more

Source:: Osteoporosis Feed

      

Last modified: June 14, 2017